[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 3 sources · 19 days · First seen · Last updated

Astera Labs revenue surge and institutional investment

Overview

Astera Labs reported a 93.5% year‑over‑year increase in quarterly revenue to $308.36 million for the quarter ended March 2026, posting a net margin of 26.72% and earnings per share of $0.61, surpassing analyst expectations. The company was added to the Nasdaq‑100 Index and is expanding operations in Taiwan to support its high‑performance cloud and AI connectivity solutions. Institutional investors boosted their stakes, with Independent Financial Group purchasing roughly $1.42 million of shares and several other firms raising or adding positions, bringing total institutional ownership to about 60% of the stock.

Entities

Atera · Proteintech Group · Cleveland Clinic · 10x Genomics · Serge Saxonov

Timeline

  1. 20 days ago

    [BUSINESS] 3 sources
    10x Genomics reports strong Atera demand in Q2 earnings

    10x Genomics posted Q2 2026 revenue of $151 million (3 % growth after settlements) and a $17.9 million loss, citing strong early orders for its Atera platform and raising full‑year guidance to $610‑$630 million

  2. about 1 month ago

    [BUSINESS] 2 sources
    Astera Labs posts rapid revenue rise and draws institutional investment

    Astera Labs' revenue jumped to $308 million with strong margins, while institutional investors, including Independent Financial Group, increased holdings worth $1.4 million.

Sources

pulse2.com · stocknews.com · tradingview.com